TABLE 1.
Demographic characteristics of total study participants by quartile of AF-ALB levels.
| AF-ALB Quartile 1 0.093>0.685* (n = 35) |
AF-ALB Quartile 2 0.685≥ 0.939* (n = 35) |
AF-ALB Quartile 3 0.939 ≥ 1.407* (n = 36) |
AF-ALB Quartile 4 1.407 ≥ 3.48* (n = 35) |
p-value | |
|---|---|---|---|---|---|
| Age mean (SD) | 39.00 (8.59) | 36.58 (8.56) | 39.54 (11.86) | 39.69 (7.28) | 0.47 |
| Sex | 12M/23F | 11M/24F | 15M/21F | 12M/23F | 0.83 |
| Mean follow-up time in days (SD) | 320 (250.72) | 216 (216.45) | 294 (283.52) | 264 (270.60) | 0.37 |
| Number on ARV’s (%) | 13 (37.14) | 9 (25.71) | 13 (36.11) | 10 (28.57) | 0.67 |
| Mean baseline CD4 count (SD) | 215.09 (130.89) | 334.89 (287.42) | 271.46 (178.82) | 363.02 (327.24) | 0.08 |
| Mean baseline viral load (SD) | 83,961.54 (240055.52) | 53,341.09 (100105.51) | 51,976.03 (129095.86) | 137,852.63 (324368.25) | 0.71 |
*
AF-ALB levels are in pmol/mg albumin